Jane Street’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-65,399
| Closed | -$1.79M | – | 6080 |
|
|
2025
Q1 | $1.79M | Buy |
65,399
+48,635
| +290% | +$1.33M | ﹤0.01% | 2375 |
|
|
2024
Q4 | $674K | Sell |
16,764
-71,710
| -81% | -$2.88M | ﹤0.01% | 3495 |
|
|
2024
Q3 | $4.19M | Sell |
88,474
-1,654
| -2% | -$78.3K | ﹤0.01% | 1515 |
|
|
2024
Q2 | $2.69M | Buy |
90,128
+49,119
| +120% | +$1.47M | ﹤0.01% | 2380 |
|
|
2024
Q1 | $1.65M | Sell |
41,009
-154,958
| -79% | -$6.23M | ﹤0.01% | 2566 |
|
|
2023
Q4 | $4.99M | Buy |
195,967
+96,915
| +98% | +$2.47M | ﹤0.01% | 1506 |
|
|
2023
Q3 | $1.38M | Sell |
99,052
-36,572
| -27% | -$508K | ﹤0.01% | 2616 |
|
|
2023
Q2 | $3.12M | Buy |
135,624
+70,850
| +109% | +$1.63M | ﹤0.01% | 1934 |
|
|
2023
Q1 | $1.92M | Sell |
64,774
-5,223
| -7% | -$155K | ﹤0.01% | 2090 |
|
|
2022
Q4 | $1.75M | Buy |
69,997
+9,273
| +15% | +$231K | ﹤0.01% | 2098 |
|
|
2022
Q3 | $1.32M | Buy |
+60,724
| New | +$1.32M | ﹤0.01% | 2499 |
|
|
2022
Q2 | – | Sell |
-13,470
| Closed | -$570K | – | 5948 |
|
|
2022
Q1 | $570K | Buy |
13,470
+6,666
| +98% | +$282K | ﹤0.01% | 3591 |
|
|
2021
Q4 | $432K | Buy |
6,804
+3,057
| +82% | +$194K | ﹤0.01% | 3632 |
|
|
2021
Q3 | $220K | Buy |
+3,747
| New | +$220K | ﹤0.01% | 4310 |
|
|
2021
Q2 | – | Sell |
-40,394
| Closed | -$1.57M | – | 5502 |
|
|
2021
Q1 | $1.57M | Buy |
40,394
+36,931
| +1,066% | +$1.44M | ﹤0.01% | 1924 |
|
|
2020
Q4 | $215K | Buy |
+3,463
| New | +$215K | ﹤0.01% | 3421 |
|